1.01
-0.03(-2.88%)
Currency In USD
| Previous Close | 1.04 |
| Open | 1.03 |
| Day High | 1.03 |
| Day Low | 1.01 |
| 52-Week High | 1.95 |
| 52-Week Low | 0.72 |
| Volume | 2,116 |
| Average Volume | 22,203 |
| Market Cap | 12.64M |
| PE | -0.21 |
| EPS | -4.83 |
| Moving Average 50 Days | 0.94 |
| Moving Average 200 Days | 1.04 |
| Change | -0.03 |
If you invested $1000 in HOOKIPA Pharma Inc. (HOOK) since IPO date, it would be worth $7.21 as of February 21, 2026 at a share price of $1.01. Whereas If you bought $1000 worth of HOOKIPA Pharma Inc. (HOOK) shares 5 years ago, it would be worth $8.53 as of February 21, 2026 at a share price of $1.01.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
GlobeNewswire Inc.
Feb 03, 2026 1:30 PM GMT
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase priceNEW YORK and VIENNA, Austria, Feb. 03, 2026 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID:
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
GlobeNewswire Inc.
Oct 31, 2025 12:00 PM GMT
NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program and certain of its assets related to HOOKIPA’s HB-500 p
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
GlobeNewswire Inc.
Jul 18, 2025 8:05 PM GMT
NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseas